Haematinics II: Clinical Pharmacological and Therapeutic Aspects

[1]  H. Olesen,et al.  Antibody to Transcobalamin II in Patients Treated with Long Acting Vitamin B12 Preparations , 2009 .

[2]  P. Neuvonen,et al.  Interference of Iron with the Absorption of Tetracylines in Man , 1970, British medical journal.

[3]  P. Elwood,et al.  A comparative trial of slow-release and conventional iron preparations. , 1970, The Practitioner.

[4]  A. Porter.  Drug Defaulting in a General Practice* , 1969, British medical journal.

[5]  I. Chanarin.  The Megaloblastic Anaemias , 1969 .

[6]  H. Olesen,et al.  Turnover of 57Co-labelled vitamin B12-transcobalamin II and autologous 131-I-labelled IgG in a patient with antibody to transcobalamin II. , 2009, Scandinavian journal of haematology.

[7]  F. Cuppage,et al.  Inhibition of intestinal iron transport induced by tetracycline. , 1967, Gastroenterology.

[8]  J. Gough,et al.  THE TREATMENT OF VITAMIN-B12 DEFICIENCY WITH A VITAMIN-B12-TANNIN COMPLEX. , 1964, Lancet.

[9]  J. Fahey,et al.  Clinical disorders of iron metabolism , 1963 .

[10]  L. Hallberg,et al.  A method for comparative studies on iron absorption in man using two radioiron isotopes. , 2009, Acta medica Scandinavica. Supplementum.

[11]  L. Hallberg,et al.  Absorbability of different iron compounds. , 2009, Acta medica Scandinavica. Supplementum.

[12]  S. Davidson,et al.  The prophylaxis of iron-deficiency anaemia in pregnancy. , 1958, Lancet.

[13]  S. Davidson,et al.  Gastrointestinal intolerance to oral iron preparations. , 1958, Lancet.

[14]  E. Beutler.  The utilization of saccharated Fe59 oxide in red cell formation. , 1958, The Journal of laboratory and clinical medicine.

[15]  T. Bothwell,et al.  Iron absorption. I. Factors influencing absorption. , 1958, The Journal of laboratory and clinical medicine.

[16]  J. Wilkinson,et al.  Oral iron compounds; a therapeutic comparison. , 1955, Lancet.